Tumor Microenvironment Responsive RNA Drug Delivery Systems: Intelligent Platforms for Sophisticated Release
Molecular Pharmaceutics · 02.09.2024 · 21 (9) · 4217-4237
DOI: 10.1021/acs.molpharmaceut.4c00334 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 26.07.2024. Verfasst von Guihua Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy & Pharmacology, University of South China, Hengyang 421001, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Drug Delivery Systems. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 144 Literaturangaben. Gefördert von: Hunan Provincial Science and Technology Department, Scientific Research Foundation of Hunan Provincial Education Department, Health Commission of Hunan Province.
Abstract (Originalsprache)
Cancer is a significant health concern, increasingly showing insensitivity to traditional treatments, highlighting the urgent need for safer and more practical treatment options. Ribonucleic acid (RNA) gene therapy drugs have demonstrated promising potential in preclinical and clinical trials for antitumor therapy by regulating tumor-related gene expression. However, RNA's poor membrane permeability and stability restrict its effectiveness in entering and being utilized in cells. An appropriate delivery system is crucial for achieving targeted tumor effects. The tumor microenvironment (TME), characterized by acidity, hypoxia, enzyme overexpression, elevated glutathione (GSH) concentration, and excessive reactive oxygen species (ROS), is essential for tumor survival. Furthermore, these distinctive features can also be harnessed to develop intelligent drug delivery systems. Various nanocarriers that respond to the TME have been designed for RNA drug delivery, showing the advantages of tumor targeting and low toxicity. This Review discusses the abnormal changes of components in TME, therapeutic RNAs' roles, underlying mechanisms, and the latest developments in utilizing vectors that respond to microenvironments for treating tumors. We hope it provides insight into creating and optimizing RNA delivery vectors to improve their effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacy & Pharmacology, University of South China, Hengyang 421001, China.
- Hunan Province Key Laboratory for Antibody-Based Drug and Intelligent Delivery System, School of Pharmaceutical Sciences, Hunan University of Medicine, Huaihua 418000, China.
- Department of Histology and Embryology, Hunan University of Chinese Medicine, Changsha 410128, China.
- College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.
ORCID-Profile: Guihua Wang, Shengsong Tang
Förderung
- Hunan Provincial Science and Technology Department
- Scientific Research Foundation of Hunan Provincial Education Department
- Health Commission of Hunan Province
- Natural Science Foundation of??Hunan Province
Zitieren
APA
Wang, G., Zhang, M., Lai, W., Gao, Y., Liao, S., Ning, Q., & Tang, S. (2024). Tumor Microenvironment Responsive RNA Drug Delivery Systems: Intelligent Platforms for Sophisticated Release. Molecular Pharmaceutics, 21(9), 4217-4237. https://doi.org/10.1021/acs.molpharmaceut.4c00334
Vancouver
Wang G, Zhang M, Lai W, Gao Y, Liao S, Ning Q, et al. Tumor Microenvironment Responsive RNA Drug Delivery Systems: Intelligent Platforms for Sophisticated Release. Molecular Pharmaceutics. 2024;21(9):4217-4237. doi:10.1021/acs.molpharmaceut.4c00334
BibTeX
@article{Wang2024,
author = {Wang, Guihua and Zhang, Mengxia and Lai, Weiwei and Gao, Yuan and Liao, Shuxian and Ning, Qian and Tang, Shengsong},
title = {Tumor Microenvironment Responsive RNA Drug Delivery Systems: Intelligent Platforms for Sophisticated Release},
journal = {Molecular Pharmaceutics},
year = {2024},
volume = {21},
number = {9},
pages = {4217--4237},
doi = {10.1021/acs.molpharmaceut.4c00334}
}
EUVIMED